US Stock MarketDetailed Quotes

ALDX Aldeyra Therapeutics

Watchlist
  • 5.270
  • -0.180-3.30%
Close Jan 6 16:00 ET
  • 5.270
  • 0.0000.00%
Post 16:37 ET
313.83MMarket Cap-7.03P/E (TTM)

Aldeyra Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
0.62%-7.97M
1.00%-13.22M
-5.60%-9.97M
46.46%-30.33M
104.46%500.44K
36.18%-8.02M
33.07%-13.36M
26.64%-9.44M
-33.09%-56.64M
2.99%-11.23M
Net income from continuing operations
-84.60%-15.11M
-87.47%-16.85M
48.24%-8.08M
39.47%-37.54M
63.16%-4.75M
43.75%-8.19M
49.46%-8.99M
6.98%-15.62M
-7.35%-62.02M
18.11%-12.9M
Depreciation and amortization
-3.10%62.99K
-4.21%61.63K
-9.47%60.63K
1.57%262.78K
-0.26%66.47K
-0.48%65K
0.51%64.34K
6.74%66.97K
-2.07%258.71K
8.77%66.64K
Other non cash items
-60.78%37.63K
-62.50%37.63K
-33.28%58.15K
6.96%354.19K
-14.51%70.75K
15.87%95.94K
21.19%100.34K
5.27%87.16K
-19.13%331.15K
-0.06%82.75K
Change In working capital
648.12%4.32M
134.60%2.11M
-283.85%-3.39M
125.00%861.18K
562.65%5.92M
-103.09%-788.2K
-69.07%-6.11M
0.31%1.84M
-146.30%-3.44M
-141.95%-1.28M
-Change in prepaid assets
1,974.10%1.34M
405.82%2.49M
-175.57%-2.82M
146.14%1.73M
56.70%-1.11M
29.40%-71.57K
-156.70%-814.44K
247.73%3.73M
-267.94%-3.76M
-205.20%-2.57M
-Change in payables and accrued expense
515.70%2.98M
92.88%-377.02K
70.12%-565.05K
-2,273.11%-6.87M
-20.23%1.03M
-149.93%-716.63K
-4.85%-5.29M
-143.35%-1.89M
-93.92%316.31K
112.53%1.29M
-Change in other working capital
----
----
----
--6M
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
0.62%-7.97M
1.00%-13.22M
-5.60%-9.97M
46.46%-30.33M
104.46%500.44K
36.18%-8.02M
33.07%-13.36M
26.64%-9.44M
-33.09%-56.64M
2.99%-11.23M
Investing cash flow
Cash flow from continuing investing activities
5.26M
-18.24M
-201.26%-30.38M
200.15%30M
0
0
0
151.70%30M
-383,637.25%-29.95M
27M
Net PPE purchase and sale
----
----
----
--0
----
----
----
----
-109.03%-16.32K
--0
Net investment purchase and sale
--5.26M
---18.24M
-201.26%-30.38M
200.21%30M
--0
--0
--0
151.71%30M
---29.94M
--27M
Cash from discontinued investing activities
Investing cash flow
--5.26M
---18.24M
-201.26%-30.38M
200.15%30M
--0
--0
--0
151.70%30M
-383,637.25%-29.95M
--27M
Financing cash flow
Cash flow from continuing financing activities
37.49%-197.39K
0
-65.39%18.19K
-204.11%-1.27M
-1.01M
-126.38%-315.76K
5.29K
125.34%52.56K
-99.37%1.22M
0
Proceeds from stock option exercised by employees
-90.85%19.87K
--0
-65.39%18.19K
-74.98%305.23K
--30.19K
-81.85%217.19K
--5.29K
125.34%52.56K
-73.96%1.22M
--0
Net other financing activities
----
----
----
---1.58M
---1.04M
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
37.49%-197.39K
--0
-65.39%18.19K
-204.11%-1.27M
---1.01M
-126.38%-315.76K
--5.29K
125.34%52.56K
-99.37%1.22M
--0
Net cash flow
Beginning cash position
-53.17%71.03M
-37.89%102.49M
-1.11%142.82M
-37.15%144.42M
11.41%143.33M
25.34%151.68M
3.85%165.03M
-37.15%144.42M
195.14%229.79M
-46.70%128.65M
Current changes in cash
65.11%-2.91M
-135.63%-31.46M
-295.70%-40.33M
98.13%-1.6M
-103.25%-511.87K
-209.19%-8.34M
64.77%-13.35M
129.07%20.61M
-156.19%-85.37M
236.20%15.77M
End cash Position
-52.47%68.12M
-53.17%71.03M
-37.89%102.49M
-1.11%142.82M
-1.11%142.82M
11.41%143.33M
25.34%151.68M
3.85%165.03M
-37.15%144.42M
-37.15%144.42M
Free cash flow
0.62%-7.97M
1.00%-13.22M
-5.60%-9.97M
46.47%-30.33M
104.46%500.44K
36.18%-8.02M
33.07%-13.36M
26.73%-9.44M
-33.10%-56.65M
2.99%-11.23M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 0.62%-7.97M 1.00%-13.22M -5.60%-9.97M 46.46%-30.33M 104.46%500.44K 36.18%-8.02M 33.07%-13.36M 26.64%-9.44M -33.09%-56.64M 2.99%-11.23M
Net income from continuing operations -84.60%-15.11M -87.47%-16.85M 48.24%-8.08M 39.47%-37.54M 63.16%-4.75M 43.75%-8.19M 49.46%-8.99M 6.98%-15.62M -7.35%-62.02M 18.11%-12.9M
Depreciation and amortization -3.10%62.99K -4.21%61.63K -9.47%60.63K 1.57%262.78K -0.26%66.47K -0.48%65K 0.51%64.34K 6.74%66.97K -2.07%258.71K 8.77%66.64K
Other non cash items -60.78%37.63K -62.50%37.63K -33.28%58.15K 6.96%354.19K -14.51%70.75K 15.87%95.94K 21.19%100.34K 5.27%87.16K -19.13%331.15K -0.06%82.75K
Change In working capital 648.12%4.32M 134.60%2.11M -283.85%-3.39M 125.00%861.18K 562.65%5.92M -103.09%-788.2K -69.07%-6.11M 0.31%1.84M -146.30%-3.44M -141.95%-1.28M
-Change in prepaid assets 1,974.10%1.34M 405.82%2.49M -175.57%-2.82M 146.14%1.73M 56.70%-1.11M 29.40%-71.57K -156.70%-814.44K 247.73%3.73M -267.94%-3.76M -205.20%-2.57M
-Change in payables and accrued expense 515.70%2.98M 92.88%-377.02K 70.12%-565.05K -2,273.11%-6.87M -20.23%1.03M -149.93%-716.63K -4.85%-5.29M -143.35%-1.89M -93.92%316.31K 112.53%1.29M
-Change in other working capital ---- ---- ---- --6M ---- ---- ---- ---- ---- ----
Cash from discontinued investing activities
Operating cash flow 0.62%-7.97M 1.00%-13.22M -5.60%-9.97M 46.46%-30.33M 104.46%500.44K 36.18%-8.02M 33.07%-13.36M 26.64%-9.44M -33.09%-56.64M 2.99%-11.23M
Investing cash flow
Cash flow from continuing investing activities 5.26M -18.24M -201.26%-30.38M 200.15%30M 0 0 0 151.70%30M -383,637.25%-29.95M 27M
Net PPE purchase and sale ---- ---- ---- --0 ---- ---- ---- ---- -109.03%-16.32K --0
Net investment purchase and sale --5.26M ---18.24M -201.26%-30.38M 200.21%30M --0 --0 --0 151.71%30M ---29.94M --27M
Cash from discontinued investing activities
Investing cash flow --5.26M ---18.24M -201.26%-30.38M 200.15%30M --0 --0 --0 151.70%30M -383,637.25%-29.95M --27M
Financing cash flow
Cash flow from continuing financing activities 37.49%-197.39K 0 -65.39%18.19K -204.11%-1.27M -1.01M -126.38%-315.76K 5.29K 125.34%52.56K -99.37%1.22M 0
Proceeds from stock option exercised by employees -90.85%19.87K --0 -65.39%18.19K -74.98%305.23K --30.19K -81.85%217.19K --5.29K 125.34%52.56K -73.96%1.22M --0
Net other financing activities ---- ---- ---- ---1.58M ---1.04M ---- ---- ---- ---- ----
Cash from discontinued financing activities
Financing cash flow 37.49%-197.39K --0 -65.39%18.19K -204.11%-1.27M ---1.01M -126.38%-315.76K --5.29K 125.34%52.56K -99.37%1.22M --0
Net cash flow
Beginning cash position -53.17%71.03M -37.89%102.49M -1.11%142.82M -37.15%144.42M 11.41%143.33M 25.34%151.68M 3.85%165.03M -37.15%144.42M 195.14%229.79M -46.70%128.65M
Current changes in cash 65.11%-2.91M -135.63%-31.46M -295.70%-40.33M 98.13%-1.6M -103.25%-511.87K -209.19%-8.34M 64.77%-13.35M 129.07%20.61M -156.19%-85.37M 236.20%15.77M
End cash Position -52.47%68.12M -53.17%71.03M -37.89%102.49M -1.11%142.82M -1.11%142.82M 11.41%143.33M 25.34%151.68M 3.85%165.03M -37.15%144.42M -37.15%144.42M
Free cash flow 0.62%-7.97M 1.00%-13.22M -5.60%-9.97M 46.47%-30.33M 104.46%500.44K 36.18%-8.02M 33.07%-13.36M 26.73%-9.44M -33.10%-56.65M 2.99%-11.23M
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion -- -- -- -- Unqualified Opinion --
Heat List
US
Overall
Symbol
Price
% Chg

No Data